{"ticker": {"uuid": "350e2440-2381-4144-857c-f6e37633f654", "symbol": "AMGN", "name": "Amgen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 81/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQNTVYdktHMlBRYUlxWi12YXVjMDdmUHVIT2hyRDBTYWEwLTlYQ25TY3p1T3hYTERYU1VPTDkySGRjU29fVnZ2NmYtaWNiX1pTM1lpemxDcEx5VGVCY1VQZUlCck9EVUFINlF2YW54NWlPQjRCRkkyUGtMUk9QaXhUaERYSEJZMmp4a25jZlJyRnV4MWlWcE5EdVVFX3luZUUxYTJGZ0JfM05iNlpqT0E?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:25:27+00:00", "published_display": "16 Jul 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/amgen-amgn-beat-estimates-again-161003809.html", "source_name": "Zacks", "published_at": "2026-07-16T16:10:03+00:00", "published_display": "16 Jul 2026 16:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN", "summary": "Wealthfront Advisers LLC increased its stake in Amgen Inc. by 10.1% in the first quarter, bringing its total holdings to 90,562 shares valued at approximately $31.9 million. This move is part of a broader trend of institutional investment, as hedge funds and other institutions ow", "url": "https://www.marketbeat.com/instant-alerts/filing-wealthfront-advisers-llc-boosts-position-in-amgen-inc-amgn-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T11:02:09", "published_display": "16 Jul 2026 11:02", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN", "summary": "D.A. Davidson & CO. reduced its stake in Amgen Inc. by 2.7% in the first quarter, selling 6,632 shares and retaining 241,522 shares valued at approximately $84.98 million. Amgen exceeded first-quarter earnings expectations, reporting an EPS of $5.15 on revenue of $8.62 billion, a", "url": "https://www.marketbeat.com/instant-alerts/filing-da-davidson-co-trims-stake-in-amgen-inc-amgn-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T08:20:04", "published_display": "16 Jul 2026 08:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp", "summary": "Bank of New York Mellon Corp decreased its stake in Amgen Inc. by 2.9% in the first quarter, selling over 113,000 shares, though still holding 3.79 million shares valued at $1.33 billion. Amgen reported strong Q1 earnings, surpassing revenue and EPS expectations. Analyst sentimen", "url": "https://www.marketbeat.com/instant-alerts/filing-amgen-inc-amgn-shares-sold-by-bank-of-new-york-mellon-corp-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T07:23:10", "published_display": "16 Jul 2026 07:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(AMGN) Price Dynamics and Execution-Aware Positioning", "summary": "This article provides an analysis of Amgen Inc. (NASDAQ: AMGN) stock, highlighting a weak near-term sentiment but strong long-term outlook. It details specific AI-generated trading strategies including long, breakout, and short positions with defined entry points, targets, and st", "url": "https://news.stocktradersdaily.com/news_release/1/AMGN_Price_Dynamics_and_Execution-Aware_Positioning_071526094602_1784166362.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T22:07:15", "published_display": "15 Jul 2026 22:07", "sentiment": "negative", "sentiment_pct": 39, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and US revenue base anchor long-term story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOWWN5dWs4NWcyY3lwdUw0T01qTTBtcU1iZjdwS09reGFidE11WVpLMDNzRFl4S1BpekxqSXhYMEc3MzdqdzB0S1NoVXFXUzhIRGx1ZHZ1elJoLXgwcTFXNHhmOWI0TVlrbzF0b1NMdmNXbFhKY1dsT0hVX01Xb0x5eldPX3g1N2hBWHlTbGZLZWkxR1dSbzBuZHdKUTg3cGtpbnlkY2VITGtDcnI4cnpwMWVvSG9YTktuRHpEd080RTJWaVhjd2NybWFB?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-15T18:01:37+00:00", "published_display": "15 Jul 2026 18:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBB ETF Holds Fewer Bets Than You Think", "summary": "The iShares Biotechnology ETF (IBB) appears diversified with 249 stocks, but its effective holdings are closer to 35 equally weighted positions due to significant concentration. The top ten holdings account for 44% of its assets, with Vertex Pharmaceuticals, Amgen, and Gilead Sci", "url": "https://www.trefis.com/stock/ibb/articles/607327/ibb-etf-holds-fewer-bets-than-you-think/2026-07-15", "source_name": "Trefis", "published_at": "2026-07-15T16:12:08", "published_display": "15 Jul 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen\u2019s Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN)", "summary": "Amgen recently initiated nationwide US recalls of certain Sensipar and Corlanor tablet lots due to FDA-identified manufacturing deviations and foreign substances. These Class II recalls raise concerns about Amgen's operational oversight and regulatory risk management, especially ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgens-tablet-recalls-test-its-quality-controls-and-manufact", "source_name": "Simply Wall Street", "published_at": "2026-07-15T15:45:23", "published_display": "15 Jul 2026 15:45", "sentiment": "negative", "sentiment_pct": 40, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Principal Financial Group Inc. Increases Stock Position in Amgen Inc. $AMGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOMWlCUjdqRmI2cmtla1d0Mm84UDQ4OEhSNXFxOXhfOENYVktLaXdtbldPaTR5RDBMX0M0YkgzRFo2Nk1TVnBkV0ZYWkJxeEplbVlidjZtZkpDX2dVcm0zR0pEQlZzbVVZUTJidHNoRWtBSDRZZDhZOW5Tei14UlVhTjAtSlVKZENZNFdBdUROa1BXMDFpMDdyZW9sTDFxRkFoenJVRmdvOGZacDBhbjhfSDFqX2ZSTVI5SU1CLWtaS19ob0k0ZWVlbnYzWUFNUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T09:37:30+00:00", "published_display": "15 Jul 2026 09:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livforsakringsbolaget Skandia Omsesidigt Purchases 10,752 Shares of Amgen Inc. $AMGN", "summary": "Livforsakringsbolaget Skandia Omsesidigt increased its stake in Amgen Inc. by 18.7% in the first quarter, now owning 68,130 shares valued at $23.95 million. This makes Amgen its 22nd biggest holding, constituting 1.0% of its portfolio. Other institutional investors also adjusted ", "url": "https://www.marketbeat.com/instant-alerts/filing-livforsakringsbolaget-skandia-omsesidigt-purchases-10752-shares-of-amgen-inc-amgn-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T10:36:06", "published_display": "15 Jul 2026 10:36", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMG National Trust Bank Has $4.59 Million Stock Position in Amgen Inc. $AMGN", "summary": "AMG National Trust Bank significantly increased its stake in Amgen Inc. to $4.59 million, holding 13,034 shares by the first quarter's end. This move follows Amgen's strong first-quarter financial performance, which exceeded revenue and EPS expectations. Despite positive analyst ", "url": "https://www.marketbeat.com/instant-alerts/filing-amg-national-trust-bank-has-459-million-stock-position-in-amgen-inc-amgn-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T07:41:09", "published_display": "15 Jul 2026 07:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "summary": "Amgen (AMGN) stock fell by 1.44% in the latest trading session, underperforming the broader market. The company's upcoming earnings report projects a 7.81% drop in EPS year-over-year, despite an expected 2.9% revenue increase. Amgen currently holds a Zacks Rank of #3 (Hold) and t", "url": "https://finance.yahoo.com/markets/stocks/articles/amgen-amgn-stock-sinks-market-215002624.html", "source_name": "Market source", "published_at": "2026-07-14T21:50:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset", "summary": "Spero Therapeutics, fresh off FDA approval for its antibiotic Utebzi, is pivoting into immunology with a new Phase 2-ready drug, SP001. This monoclonal antibody, licensed from Innovent Biologics, targets CD40 ligand and will be developed for immunoglobulin G4-related disease (IgG", "url": "https://medcitynews.com/2026/07/spero-pivots-immunology-inflammation-igg4-rd-spro/", "source_name": "MedCity News", "published_at": "2026-07-14T20:22:11", "published_display": "14 Jul 2026 20:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer Vs. Amgen: Bet That Pfizer\u2019s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen", "summary": "", "url": "https://finance.yahoo.com/m/1954900f-b2a1-364c-bd2f-e7a4e3223ffa/pfizer-vs.-amgen%3A-bet-that.html", "source_name": "24/7 Wall St.", "published_at": "2026-07-14T15:51:03+00:00", "published_display": "14 Jul 2026 15:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. stock outperforms competitors despite losses on the day", "summary": "Amgen Inc. (AMGN) shares fell by 1.44% to $355.25 on Tuesday, marking its fifth consecutive day of losses, despite a favorable trading session for the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains.", "url": "https://www.marketwatch.com/data-news/amgen-inc-stock-outperforms-competitors-despite-losses-on-the-day-f2abb153-867dd9655c2b?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-14T16:34:00", "published_display": "14 Jul 2026 16:34", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNRG5OTW8wMmFjUDA3LTNQN3BReTlkMlFsUTllZTN3bm5yWFRjYm02VTVZeXgwUC1ibDgyS0F6V2V4MHJQQ25CVUE1di13RTQ2SFZYMHR5M21DVjhnMDQ5NE5VTlJoRndIQ0tONkZtTTRVTmI0Y0VvQ0VNZnp3NVRQRk43clg1X0RlV0tGckpsNldxQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-14T15:13:44+00:00", "published_display": "14 Jul 2026 15:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen", "summary": "This article contrasts Pfizer and Amgen, arguing that Pfizer offers a better investment in oncology due to its successful integration of Seagen and existing revenue streams. Pfizer trades at a lower forward P/E of 8x with a substantial 7% dividend yield, while Amgen faces signifi", "url": "https://247wallst.com/investing/2026/07/14/pfizer-vs-amgen-bet-that-pfizers-seagen-integration-leads-to-long-term-oncology-alpha-over-amgen/", "source_name": "24/7 Wall St.", "published_at": "2026-07-14T15:51:00", "published_display": "14 Jul 2026 15:51", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Colo. Win May Chill States' Push To Cap Drug Prices", "summary": "A recent victory for Amgen in Colorado could slow down states' efforts to set limits on prescription drug prices. Colorado was the first state to announce a price cap on a medication, marking a significant step in state-level drug regulation. The full article is behind a paywall,", "url": "https://www.law360.com/articles/2500770/amgen-colo-win-may-chill-states-push-to-cap-drug-prices", "source_name": "Law360", "published_at": "2026-07-14T12:58:00", "published_display": "14 Jul 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC", "summary": "Mattern Capital Management LLC reduced its stake in Amgen Inc. by 30.9% in the first quarter, selling 10,686 shares and retaining 23,890. Despite this, Amgen exceeded Q1 earnings expectations with EPS of $5.15 and reaffirmed its FY2026 EPS guidance. While analysts maintain a \"Hol", "url": "https://www.marketbeat.com/instant-alerts/filing-amgen-inc-amgn-shares-sold-by-mattern-capital-management-llc-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T10:21:10", "published_display": "14 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HRMY vs. AMGN: Which Stock Is the Better Value Option?", "summary": "This article from Zacks Equity Research compares Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN) to determine which is a better value stock. Utilizing the Zacks Rank and Style Scores, particularly the Value category, the analysis concludes that HRMY is the superior val", "url": "https://ca.finance.yahoo.com/news/hrmy-vs-amgn-stock-better-154004630.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-14T08:40:00", "published_display": "14 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN", "summary": "Calamos Advisors LLC increased its stake in Amgen Inc. by 5.1% in the first quarter, purchasing an additional 3,648 shares which brought their total holding to 75,496 shares valued at approximately $26.6 million. Wall Street analysts have a \"Hold\" consensus rating for Amgen with ", "url": "https://www.marketbeat.com/instant-alerts/filing-calamos-advisors-llc-buys-3648-shares-of-amgen-inc-amgn-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T08:21:09", "published_display": "14 Jul 2026 08:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape", "summary": "The late stage Chronic Kidney Disease (CKD) Therapeutics Market, valued at $13.02 billion in 2025, is projected to reach $25.20 billion by 2032, growing at a CAGR of 9.88%. This growth is driven by technological advancements, a shift towards integrated cardio-renal-metabolic stra", "url": "https://sg.finance.yahoo.com/news/advancements-ckd-care-therapies-astrazeneca-081600303.html", "source_name": "Market source", "published_at": "2026-07-14T08:15:09", "published_display": "14 Jul 2026 08:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGD Bond Profile \u2014 Key Metrics", "summary": "This article provides a bond profile for Amgen Inc.'s AMGD bond (4.2% 22-FEB-2052). It details key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. Amgen Inc. is identified as a biotechnology company fou", "url": "https://www.tradingview.com/symbols/GETTEX-AMGD/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T07:37:16", "published_display": "14 Jul 2026 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN", "summary": "Bleakley Financial Group LLC increased its stake in Amgen Inc. by 12.0% in the first quarter, adding 3,526 shares and bringing its total holding to 32,930 shares valued at $11.6 million. This aligns with high institutional interest in Amgen, where 76.5% of shares are institutiona", "url": "https://www.marketbeat.com/instant-alerts/filing-bleakley-financial-group-llc-purchases-3526-shares-of-amgen-inc-amgn-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T07:33:06", "published_display": "14 Jul 2026 07:33", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here\u2019s What It Means for the Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQcUVIcmVrNTd2TUpLVXRfSU1jc3MzMDNtdkRNUHNwUm5PUS1OTEVmTGxZdlBPWHBfUDVIeWtsQ0JqdFJUYjR3OWZSMXh6c2NodTlScDJ6SldWbXBTWlV4ei11bFpxWGRNcVhBbzBEOFlfRlB6ZFVsTElMVWNoQ3Z0aTN5b2xYaF9scWJMZE1yRXRDVjNITDVIaHcwQXowVF9KT2owOWhnN3c3ZFFKYmxKMDkxb2RYYkxVaWdVbDFxWkQtVFZub2swMw?oc=5", "source_name": "TIKR.com", "published_at": "2026-07-13T16:09:28+00:00", "published_display": "13 Jul 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNNmh5YWVCa0dxTk54bmlfX1ZrRzhXMVU3TWptbHdyTVlZQklVaUtoOThHLVpGYzg2amdXUEp2ZVNIbDgyOXdGdU91ZnppbXVRMmJFLWZJQUFrdkpNQXFwQkQ1TUo5QzNmQWsxRVk3MkNpcEdlMnpVa21aSGxhektrMTdjUWZLUGhCclFYSGVfMGRBR0cxcUFJRGt3?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:00:04+00:00", "published_display": "13 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNWGk1OVlqZzJieTNGcEpISGRpbU9Mcjd6elVOalNQN3VlcTNYMXUzNTZpQ1V4cHVqMURHaEJreTNUUmpJSHBGd1l0OGc0SnlsR25RZldwS1VjZVZNczJpVUVrbVhCakhpTUc1MkF4dmJxUkVVVEc5RTg4alF1UUlGdkxGQ3dmQmw3S2NDSzJjNjlhTTZYUFlTa2J5ekV6UXJjRWdnaDhxZEFzLUlQVm0wT2pKX1IxM3pMVU9ZaTktRQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T12:49:44+00:00", "published_display": "13 Jul 2026 12:49", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim raises Amgen stock price target to $343 on product mix", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMWhVVXVqVHA5cEV0TDdkZDNINW84VDhyUzRUOVI5SHhwcVZ1YzhVSkRzWmtGSEVZalRjMFdGZ00yTnoxZ1NURkRsdzZ3OTNrdnlOR3FXOWJoeXBRcWhhN3FoUGJhRWc3Vm9aMF92bHBTVzBBSmVjMzh0WXRZdVRzMzBTbFU4MDU2bF9yQXdSYktDRUNuZjh0TU1qbVpsdFN6VUVNMEV1WmUza0xyV0E0Z3Axa3RrSzFzOE1qeE1BbGl0UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:16:10+00:00", "published_display": "13 Jul 2026 12:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA raises Amgen stock price target on growth franchise execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQMnA4SDAxUF9ISl9hRXUxc3dXRUJ0LW9uWWFjNGZiRnhvbzJRLWdZanpPM2h6SDl2eUpWQU5PR3ZtdVNwNzJrU0xCaDBXYXdEaGx1cnVncGtBS25acEZFbGJxSm1SS3ptVDNvbjJHTTZ4SV9tUU9XSHRyd1U1ZFZVcjVoYUZnVzVidl9VY0RzUUdsRkdLMWR6b3ZwZ29RMGFWanpmUWlkRko2Ull3eEQyVWVUNjNFV0tuSm9QMDgxV3Y4OS1B?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T10:34:43+00:00", "published_display": "13 Jul 2026 10:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Analyst Ratings, Stock Forecast and Price Target", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T03:09:35+00:00", "published_display": "13 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPclRZS1B6QzF6SndzNnIyOFZaekRzX2g0Qk93bUpfUXhIRm1XYXJkODgzaDhVRmk4UThQUE5lM2YzZUxOZXZ6SWVBWENSQlNWNFB6cWNod0QzVndVcHRVdXRQb3pEMVp2X3hmS1NfZnRhd2lHYldobXY3dnIwRzVYNkswdFNIVGRRQ1V4eTIwVWJCU1lYekgzVFh6NUktVWhlYV9DZWpqb1c2WF83SFozYTBNRVEyMlJpYkxkMTI0amd0SkxYZWc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-12T18:37:26+00:00", "published_display": "12 Jul 2026 18:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQVUZmcEVWci0wNm50LS1sR1d0UGZXaHJQbW5BLVhoOGs2cHNJMGNmb0NaWlA5MTMzaXU3OFR5VmJOTWk0MlFHNXI3NkVjNjlUNnc5ekcwSDZlWU8wWHNzVlppUzlPNlNtSGp0WjBZQjNGT2VxemNRVXVvbzR2N196aXZWRVBTbzhORTUydjdDb1BtU0tqZ2RjQWY3Mk5QN1gtcWZLbTFzbWs3NEdxSG1QamF0N3R1TVZiNGhhSm1oNlhPUWQyYkhXWnNVRE0?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T09:32:31+00:00", "published_display": "11 Jul 2026 09:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOWUtPeXFhVmNlMG9yczZQSmloREtPelJ1dUk5X25RN2xjWTh0eW9yNW1nVmRTV0dFSWh4akl3X0gyaDZwaXJQbUZ1bkZRanIxUzdqbnNpWHV1ckhVNzBfako4QVRta0tGdXdBc0s4TjdQQk54enVNd2xvTjNMem4tN0l5R2VFdTVrNkdsM2VFbHpKVXl6cktRNHg3WTBKenpWbmZFa0NuU3pYNUNqbU1KWUVKUWF4TUp1dllpOF8xeHpIOXVCNnc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-10T18:02:26+00:00", "published_display": "10 Jul 2026 18:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen highlights its science-driven pipeline as investors weigh long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUDBmSW42T3VmdXM5ekRNRDVaYmlyVEI4NDFENGpkUGlMU2VINE1PMEl2NWU1bUU5UDJJblUyS0tXUk5BNmRnanZ5ZjhSWFgwNThzQmtiRjVkUnlJV3MtVWVSb2xWaHVsdzh2dEh1WjBzeFY2elRqYjhFYzJKdnZWWVRRejMxY3Y1WnItOHA0YTNJWTRMbUxwdGQ4N192RW1oMXp1Q2NlYWx0TGtHS2k3bHh5OFBUeWV2N25pVmZnSGI0LVdwc2hMUmJ1SWQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-07T11:26:47+00:00", "published_display": "07 Jul 2026 11:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQTG9jeEVHV1R0YzRUd2ZMakFrdFgyNW1oY3ZhRXFlT3ZKLWZUZlhaOHdsdld5ZWxmR1k1M0E5V0pBNGN2RjctZXhRZHFfNmpNdjBmQXpuc2Y5N3hPNUY2M3NRdjV3cGZLT19MLWI3c1VDaFRoTk1rRGlNM2JkYzZsdlkxSkVlUG9nb2FlaXhoR3lqc09fV1RN?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaWJ3VU81UWdRY1V5UnE3c0F5Y0Z6aGE1aGViUjJZZ2syRjZ0TEJnNENkRERheWxHUGJHeEt2U3VQRHloZmN6SjR1OHpsZnhOLWpOWXVja0xQSmszWHY4Wm1YbUVEcXg2NEExcGRXQnF0Q2pWWXVtc1pzQVFYWUU2UGtCNENKLVlsbzBRMjBtSy1NNFdFQ1RRNWh0ZGZwNTlkTGZhN2k4cFhrZw?oc=5", "source_name": "StockStory", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen or Biogen: Which Biotech Stock Appears Better Poised?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxON1BCVkVBZzJtX2tLMjg3OTJiV1NlYnYxcHd6ZjdMRmRoaEpnV2tEYkdPOUFKQmc3ZDQ0WWlQXy1fTXYtd1NhQm9sZDdGajBYMVNsQ250TkhjNU1lUGNDSnpldUZseWpFb3pHT1NodEd6T2xIRmFVSU1jU0hNemZCaVNfTWlwYnp6UnVhM1FQcDBOMG81dXdJZHpSbw?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOeGV4VzN2aDFGX1MxcDROeHdGRDlvaUZQbi1sUnNQc2RUYWhUcXduY0FCUzcxaDBfSzJFeElMNjZjdm95RUF1U3Jqel9RRGQtV2JnNmF2T29NZlkwVkxlLVRKV0E4XzVxS1FLWVMtOHdsdDlqT01vcGxlQjBmcUR3RWgyQXlFZlZQWkV2bXpoSWpmTmFscHlFRzRuMA?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock After Horizon Deal And Strong Multi\u2011Year Gains Is Price Still Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQUEk5QTkyT0x2SHp2RFl3SlVLWXR4Zm52N090UmJyLVp5Z0VYdFlEeERFV1phOE1FS1ViYWdrNkh5VmNLbXJtWFp4b1FBUVF1MHdSN21zYXFOWWdVSjJLanlWVTUxbkQyTGhGYV9tVHJqVGgwOVZKWmFHYmJjeXZIN0xXVVZZVlA4MFMwZUZfU29tdXUybnJWeUFkMU1DQ1pocXBUVHhweUpoRjg3ZjkyaldnWGw1Z1U?oc=5", "source_name": "TradingView", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPOHZoUHZHV2tSUk1FamJ2dlpGRHhwRF9wUlU5cVIyYVQyTFJuSjlfOXpJUkEzbVI4aWRPd3hVTXZkX2xvaVNzNVR4bDdVakhGdmNoWE9PUi01NVdGZnhnbUVfd1lMYl80N3B2UUtRSDQ2aWJfN0F2VTJySHB4Q253WXNLam10UEJnU1E3bndnY3plRnlRTm5wdEFqeUdnZw?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen finance and R&D chiefs will speak in a public webcast May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNSWxzODIxSk5CNEwxUWJLU0JZb3ZhOWhWcVFSZHZqOFVTcDVZc29zeVBFdU9QRWcycTRvSXVHa1ZHT2ZENUU0MkdnS2JhOEpMaGFYb2ZPVG9HVGo3aERJTkNnT01jWnhaWGpCRlNuWVo5cDNyVnozVHFqUnpmWVMtQ3pMUGhYSENWaGhFRzI2Q2dXTHJvTHBsQVBpaDRXMHdtYWR0dUFPSmF3TFkydGlVVGZqd1E3dw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNnk5T1gtWUJjNV9oRlJrTS1YQ09Gb2tRVDdyellvTGp1TFdRelI0a25ha0VXOW5IZnJDRkFlVzRQYm51Tm5LZ1ZkUGN3QU9xMUdVX1VoclkyalFNbktmOG5PdDBENzB6QXlIWVFzVFU5R01DYXRKQjZqWmZTMFY3U0swYmZrNVdQUVE1OWltMWJFZl91LWhLT2ZXOHNLaXh0SkcxeGpBdFVDQmVaYmZXRWhlWWdFOVVnVncwTGNHUVVhQ0ZuOVd5YzZGTWI3OUNlbVhmYWIyeXR0bW1wUGQtQjN1dGdCTm1EdzRBck1NSUZ6RUQzNTRhNGhBUQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNTE5icUl3Z0RGR21FRmh2aHJFRGNJY002ZFdIV0RkMFA3TFZySW9xODdxMDZfckU2Mmp4S2lCeWpIOTJpU0xXX09zWExZNTBYM09BUFJIaDRMMHRBZHVjaWJKSE1QN0dPOVYzQnlvZWpadE16ZDZjVXZBN1NPOTJfV0dMbUNoY2RFeVh4UUJFU2hHa0Z6RTRaU0ktVEpUUkRNc2RLa2JsdzB3NVN1V2NzUmxZcmhyal84eU44d1R5dWJGM0RMUm12dzI1djQ0bjRfN0VIZXNR0gHbAUFVX3lxTE9CNVhfdDlLNmFfNnpqWmZnVVNwNE5VY1c5aThWZ0ptb3Ytczc2SVdwMWROdGFkdjJwU1EzNi15Um12dkFiYU8zWlZ6M3BzWW9nS2dHVlV1VnN6dUZmbEFOSHFuWGtlRTVDZzlodFVBdnhUZFBIaWt0NVg3QllsWkc1a0k2d21aRDU4VXk2Sm9CU3VZMGM0cWFjdmxxYm9HNnB1NVNINWNPRk1hUm1qMWVhMF9hQV9hR0Ywdlo5bktZUkZYdlB1aHF1RkY5ZnV5LUtmMDkxM25CcDdSSQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen CEO Teases 2026 As \u2018Springboard Year\u2019 After 14 Blockbusters And 18 Record Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQcUhyZXo1WVlWVDFnVjdiSlFLMFM4LVBENVRORV82TnlNQXQxd1ZJMEh1VmdzSGVlYXo3Tm0xOERxYnRVTUowUm5Db181d3lha0F6LU96UGtUZ0dYdnZYeGtncGtFejZzcktuMlRjVVdSR1FfR2swb3huNmYxeEFiTUFKSVRRTHVaMDRBZEFBcEN1S1p5NzVneGhsUXphTFZwVkdoa3R1MGZnTFA1YkE3M0NveTFpeHRLRDlpX2tJT2JaQS1RS01MOHdGd2tZZHFqZm1SejgzT0dPR2M4?oc=5", "source_name": "Stocktwits", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq falls 1.5% amid heavy rotation out of tech stocks; Amgen boosts Dow", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPdHJkeV9sUHZlOWNBbFZHMVNCS0g4S2Vsc3VIMVhmSVNXQklSTWw3Q2ZBVHZMelh1MktteDZibXJZeVhEMk9JM29JZGxCRG5fel9wendVLTdFT2dVYWgwS1BlY2xyNHUwRk5NbDVEOUlpa1A5RjIxWldrUC0tQnVGbGR1U2hNYkgweDZYUzYzSnF3VTU5OVJvYjlKbmZKZ3diUFNtbFl6MTdMb3pPaDVJd1F6VTBLQ0NDWl9WcWpOOE1SdkRYMHR5VnEtcTYtUk0?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOUzdHeGdUbzBLOVBRRDVBWFY0VGdaZlpIRGxjQ012VFhxVjU4ZXAyZm5mVGZQZnE0cWhNaHFWVE55TW5xeEEtZDRsNm55MkRkeDJyWVdINS1haDNQS3JPYlNTZG8tbVdSX25walRqWTNKTXMwTmFvTUpqeGZBazRYT18zZWFRSXhMSUFCbjZKNTA2bDR0ZVVTVUZRUFpqaDZoWWhDekdKb29wdjZnLU12ZmNGbXRxWkhQYS13YXZ3QzFRVGVnOENReFVjM0l2NWM1WTBFcHpUdDJyZVNpYWV0aDBPRkExdw?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Ignore The Insider Selling In Amgen", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5", "source_name": "The American Journal of Managed Care\u00ae (AJMC\u00ae)", "published_at": "2025-10-06T07:00:00+00:00", "published_display": "06 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 81/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQNTVYdktHMlBRYUlxWi12YXVjMDdmUHVIT2hyRDBTYWEwLTlYQ25TY3p1T3hYTERYU1VPTDkySGRjU29fVnZ2NmYtaWNiX1pTM1lpemxDcEx5VGVCY1VQZUlCck9EVUFINlF2YW54NWlPQjRCRkkyUGtMUk9QaXhUaERYSEJZMmp4a25jZlJyRnV4MWlWcE5EdVVFX3luZUUxYTJGZ0JfM05iNlpqT0E?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:25:27+00:00", "published_display": "16 Jul 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/amgen-amgn-beat-estimates-again-161003809.html", "source_name": "Zacks", "published_at": "2026-07-16T16:10:03+00:00", "published_display": "16 Jul 2026 16:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN", "summary": "Wealthfront Advisers LLC increased its stake in Amgen Inc. by 10.1% in the first quarter, bringing its total holdings to 90,562 shares valued at approximately $31.9 million. This move is part of a broader trend of institutional investment, as hedge funds and other institutions ow", "url": "https://www.marketbeat.com/instant-alerts/filing-wealthfront-advisers-llc-boosts-position-in-amgen-inc-amgn-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T11:02:09", "published_display": "16 Jul 2026 11:02", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN", "summary": "D.A. Davidson & CO. reduced its stake in Amgen Inc. by 2.7% in the first quarter, selling 6,632 shares and retaining 241,522 shares valued at approximately $84.98 million. Amgen exceeded first-quarter earnings expectations, reporting an EPS of $5.15 on revenue of $8.62 billion, a", "url": "https://www.marketbeat.com/instant-alerts/filing-da-davidson-co-trims-stake-in-amgen-inc-amgn-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T08:20:04", "published_display": "16 Jul 2026 08:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp", "summary": "Bank of New York Mellon Corp decreased its stake in Amgen Inc. by 2.9% in the first quarter, selling over 113,000 shares, though still holding 3.79 million shares valued at $1.33 billion. Amgen reported strong Q1 earnings, surpassing revenue and EPS expectations. Analyst sentimen", "url": "https://www.marketbeat.com/instant-alerts/filing-amgen-inc-amgn-shares-sold-by-bank-of-new-york-mellon-corp-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T07:23:10", "published_display": "16 Jul 2026 07:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(AMGN) Price Dynamics and Execution-Aware Positioning", "summary": "This article provides an analysis of Amgen Inc. (NASDAQ: AMGN) stock, highlighting a weak near-term sentiment but strong long-term outlook. It details specific AI-generated trading strategies including long, breakout, and short positions with defined entry points, targets, and st", "url": "https://news.stocktradersdaily.com/news_release/1/AMGN_Price_Dynamics_and_Execution-Aware_Positioning_071526094602_1784166362.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T22:07:15", "published_display": "15 Jul 2026 22:07", "sentiment": "negative", "sentiment_pct": 39, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and US revenue base anchor long-term story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOWWN5dWs4NWcyY3lwdUw0T01qTTBtcU1iZjdwS09reGFidE11WVpLMDNzRFl4S1BpekxqSXhYMEc3MzdqdzB0S1NoVXFXUzhIRGx1ZHZ1elJoLXgwcTFXNHhmOWI0TVlrbzF0b1NMdmNXbFhKY1dsT0hVX01Xb0x5eldPX3g1N2hBWHlTbGZLZWkxR1dSbzBuZHdKUTg3cGtpbnlkY2VITGtDcnI4cnpwMWVvSG9YTktuRHpEd080RTJWaVhjd2NybWFB?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-15T18:01:37+00:00", "published_display": "15 Jul 2026 18:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBB ETF Holds Fewer Bets Than You Think", "summary": "The iShares Biotechnology ETF (IBB) appears diversified with 249 stocks, but its effective holdings are closer to 35 equally weighted positions due to significant concentration. The top ten holdings account for 44% of its assets, with Vertex Pharmaceuticals, Amgen, and Gilead Sci", "url": "https://www.trefis.com/stock/ibb/articles/607327/ibb-etf-holds-fewer-bets-than-you-think/2026-07-15", "source_name": "Trefis", "published_at": "2026-07-15T16:12:08", "published_display": "15 Jul 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen\u2019s Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN)", "summary": "Amgen recently initiated nationwide US recalls of certain Sensipar and Corlanor tablet lots due to FDA-identified manufacturing deviations and foreign substances. These Class II recalls raise concerns about Amgen's operational oversight and regulatory risk management, especially ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgens-tablet-recalls-test-its-quality-controls-and-manufact", "source_name": "Simply Wall Street", "published_at": "2026-07-15T15:45:23", "published_display": "15 Jul 2026 15:45", "sentiment": "negative", "sentiment_pct": 40, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Principal Financial Group Inc. Increases Stock Position in Amgen Inc. $AMGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOMWlCUjdqRmI2cmtla1d0Mm84UDQ4OEhSNXFxOXhfOENYVktLaXdtbldPaTR5RDBMX0M0YkgzRFo2Nk1TVnBkV0ZYWkJxeEplbVlidjZtZkpDX2dVcm0zR0pEQlZzbVVZUTJidHNoRWtBSDRZZDhZOW5Tei14UlVhTjAtSlVKZENZNFdBdUROa1BXMDFpMDdyZW9sTDFxRkFoenJVRmdvOGZacDBhbjhfSDFqX2ZSTVI5SU1CLWtaS19ob0k0ZWVlbnYzWUFNUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T09:37:30+00:00", "published_display": "15 Jul 2026 09:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Livforsakringsbolaget Skandia Omsesidigt Purchases 10,752 Shares of Amgen Inc. $AMGN", "summary": "Livforsakringsbolaget Skandia Omsesidigt increased its stake in Amgen Inc. by 18.7% in the first quarter, now owning 68,130 shares valued at $23.95 million. This makes Amgen its 22nd biggest holding, constituting 1.0% of its portfolio. Other institutional investors also adjusted ", "url": "https://www.marketbeat.com/instant-alerts/filing-livforsakringsbolaget-skandia-omsesidigt-purchases-10752-shares-of-amgen-inc-amgn-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T10:36:06", "published_display": "15 Jul 2026 10:36", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMG National Trust Bank Has $4.59 Million Stock Position in Amgen Inc. $AMGN", "summary": "AMG National Trust Bank significantly increased its stake in Amgen Inc. to $4.59 million, holding 13,034 shares by the first quarter's end. This move follows Amgen's strong first-quarter financial performance, which exceeded revenue and EPS expectations. Despite positive analyst ", "url": "https://www.marketbeat.com/instant-alerts/filing-amg-national-trust-bank-has-459-million-stock-position-in-amgen-inc-amgn-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T07:41:09", "published_display": "15 Jul 2026 07:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "summary": "Amgen (AMGN) stock fell by 1.44% in the latest trading session, underperforming the broader market. The company's upcoming earnings report projects a 7.81% drop in EPS year-over-year, despite an expected 2.9% revenue increase. Amgen currently holds a Zacks Rank of #3 (Hold) and t", "url": "https://finance.yahoo.com/markets/stocks/articles/amgen-amgn-stock-sinks-market-215002624.html", "source_name": "Market source", "published_at": "2026-07-14T21:50:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset", "summary": "Spero Therapeutics, fresh off FDA approval for its antibiotic Utebzi, is pivoting into immunology with a new Phase 2-ready drug, SP001. This monoclonal antibody, licensed from Innovent Biologics, targets CD40 ligand and will be developed for immunoglobulin G4-related disease (IgG", "url": "https://medcitynews.com/2026/07/spero-pivots-immunology-inflammation-igg4-rd-spro/", "source_name": "MedCity News", "published_at": "2026-07-14T20:22:11", "published_display": "14 Jul 2026 20:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer Vs. Amgen: Bet That Pfizer\u2019s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen", "summary": "", "url": "https://finance.yahoo.com/m/1954900f-b2a1-364c-bd2f-e7a4e3223ffa/pfizer-vs.-amgen%3A-bet-that.html", "source_name": "24/7 Wall St.", "published_at": "2026-07-14T15:51:03+00:00", "published_display": "14 Jul 2026 15:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. stock outperforms competitors despite losses on the day", "summary": "Amgen Inc. (AMGN) shares fell by 1.44% to $355.25 on Tuesday, marking its fifth consecutive day of losses, despite a favorable trading session for the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains.", "url": "https://www.marketwatch.com/data-news/amgen-inc-stock-outperforms-competitors-despite-losses-on-the-day-f2abb153-867dd9655c2b?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-14T16:34:00", "published_display": "14 Jul 2026 16:34", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNRG5OTW8wMmFjUDA3LTNQN3BReTlkMlFsUTllZTN3bm5yWFRjYm02VTVZeXgwUC1ibDgyS0F6V2V4MHJQQ25CVUE1di13RTQ2SFZYMHR5M21DVjhnMDQ5NE5VTlJoRndIQ0tONkZtTTRVTmI0Y0VvQ0VNZnp3NVRQRk43clg1X0RlV0tGckpsNldxQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-14T15:13:44+00:00", "published_display": "14 Jul 2026 15:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen", "summary": "This article contrasts Pfizer and Amgen, arguing that Pfizer offers a better investment in oncology due to its successful integration of Seagen and existing revenue streams. Pfizer trades at a lower forward P/E of 8x with a substantial 7% dividend yield, while Amgen faces signifi", "url": "https://247wallst.com/investing/2026/07/14/pfizer-vs-amgen-bet-that-pfizers-seagen-integration-leads-to-long-term-oncology-alpha-over-amgen/", "source_name": "24/7 Wall St.", "published_at": "2026-07-14T15:51:00", "published_display": "14 Jul 2026 15:51", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Colo. Win May Chill States' Push To Cap Drug Prices", "summary": "A recent victory for Amgen in Colorado could slow down states' efforts to set limits on prescription drug prices. Colorado was the first state to announce a price cap on a medication, marking a significant step in state-level drug regulation. The full article is behind a paywall,", "url": "https://www.law360.com/articles/2500770/amgen-colo-win-may-chill-states-push-to-cap-drug-prices", "source_name": "Law360", "published_at": "2026-07-14T12:58:00", "published_display": "14 Jul 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC", "summary": "Mattern Capital Management LLC reduced its stake in Amgen Inc. by 30.9% in the first quarter, selling 10,686 shares and retaining 23,890. Despite this, Amgen exceeded Q1 earnings expectations with EPS of $5.15 and reaffirmed its FY2026 EPS guidance. While analysts maintain a \"Hol", "url": "https://www.marketbeat.com/instant-alerts/filing-amgen-inc-amgn-shares-sold-by-mattern-capital-management-llc-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T10:21:10", "published_display": "14 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HRMY vs. AMGN: Which Stock Is the Better Value Option?", "summary": "This article from Zacks Equity Research compares Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN) to determine which is a better value stock. Utilizing the Zacks Rank and Style Scores, particularly the Value category, the analysis concludes that HRMY is the superior val", "url": "https://ca.finance.yahoo.com/news/hrmy-vs-amgn-stock-better-154004630.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-14T08:40:00", "published_display": "14 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN", "summary": "Calamos Advisors LLC increased its stake in Amgen Inc. by 5.1% in the first quarter, purchasing an additional 3,648 shares which brought their total holding to 75,496 shares valued at approximately $26.6 million. Wall Street analysts have a \"Hold\" consensus rating for Amgen with ", "url": "https://www.marketbeat.com/instant-alerts/filing-calamos-advisors-llc-buys-3648-shares-of-amgen-inc-amgn-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T08:21:09", "published_display": "14 Jul 2026 08:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape", "summary": "The late stage Chronic Kidney Disease (CKD) Therapeutics Market, valued at $13.02 billion in 2025, is projected to reach $25.20 billion by 2032, growing at a CAGR of 9.88%. This growth is driven by technological advancements, a shift towards integrated cardio-renal-metabolic stra", "url": "https://sg.finance.yahoo.com/news/advancements-ckd-care-therapies-astrazeneca-081600303.html", "source_name": "Market source", "published_at": "2026-07-14T08:15:09", "published_display": "14 Jul 2026 08:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGD Bond Profile \u2014 Key Metrics", "summary": "This article provides a bond profile for Amgen Inc.'s AMGD bond (4.2% 22-FEB-2052). It details key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. Amgen Inc. is identified as a biotechnology company fou", "url": "https://www.tradingview.com/symbols/GETTEX-AMGD/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T07:37:16", "published_display": "14 Jul 2026 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN", "summary": "Bleakley Financial Group LLC increased its stake in Amgen Inc. by 12.0% in the first quarter, adding 3,526 shares and bringing its total holding to 32,930 shares valued at $11.6 million. This aligns with high institutional interest in Amgen, where 76.5% of shares are institutiona", "url": "https://www.marketbeat.com/instant-alerts/filing-bleakley-financial-group-llc-purchases-3526-shares-of-amgen-inc-amgn-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T07:33:06", "published_display": "14 Jul 2026 07:33", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here\u2019s What It Means for the Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQcUVIcmVrNTd2TUpLVXRfSU1jc3MzMDNtdkRNUHNwUm5PUS1OTEVmTGxZdlBPWHBfUDVIeWtsQ0JqdFJUYjR3OWZSMXh6c2NodTlScDJ6SldWbXBTWlV4ei11bFpxWGRNcVhBbzBEOFlfRlB6ZFVsTElMVWNoQ3Z0aTN5b2xYaF9scWJMZE1yRXRDVjNITDVIaHcwQXowVF9KT2owOWhnN3c3ZFFKYmxKMDkxb2RYYkxVaWdVbDFxWkQtVFZub2swMw?oc=5", "source_name": "TIKR.com", "published_at": "2026-07-13T16:09:28+00:00", "published_display": "13 Jul 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNNmh5YWVCa0dxTk54bmlfX1ZrRzhXMVU3TWptbHdyTVlZQklVaUtoOThHLVpGYzg2amdXUEp2ZVNIbDgyOXdGdU91ZnppbXVRMmJFLWZJQUFrdkpNQXFwQkQ1TUo5QzNmQWsxRVk3MkNpcEdlMnpVa21aSGxhektrMTdjUWZLUGhCclFYSGVfMGRBR0cxcUFJRGt3?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:00:04+00:00", "published_display": "13 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNWGk1OVlqZzJieTNGcEpISGRpbU9Mcjd6elVOalNQN3VlcTNYMXUzNTZpQ1V4cHVqMURHaEJreTNUUmpJSHBGd1l0OGc0SnlsR25RZldwS1VjZVZNczJpVUVrbVhCakhpTUc1MkF4dmJxUkVVVEc5RTg4alF1UUlGdkxGQ3dmQmw3S2NDSzJjNjlhTTZYUFlTa2J5ekV6UXJjRWdnaDhxZEFzLUlQVm0wT2pKX1IxM3pMVU9ZaTktRQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T12:49:44+00:00", "published_display": "13 Jul 2026 12:49", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim raises Amgen stock price target to $343 on product mix", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMWhVVXVqVHA5cEV0TDdkZDNINW84VDhyUzRUOVI5SHhwcVZ1YzhVSkRzWmtGSEVZalRjMFdGZ00yTnoxZ1NURkRsdzZ3OTNrdnlOR3FXOWJoeXBRcWhhN3FoUGJhRWc3Vm9aMF92bHBTVzBBSmVjMzh0WXRZdVRzMzBTbFU4MDU2bF9yQXdSYktDRUNuZjh0TU1qbVpsdFN6VUVNMEV1WmUza0xyV0E0Z3Axa3RrSzFzOE1qeE1BbGl0UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:16:10+00:00", "published_display": "13 Jul 2026 12:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA raises Amgen stock price target on growth franchise execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQMnA4SDAxUF9ISl9hRXUxc3dXRUJ0LW9uWWFjNGZiRnhvbzJRLWdZanpPM2h6SDl2eUpWQU5PR3ZtdVNwNzJrU0xCaDBXYXdEaGx1cnVncGtBS25acEZFbGJxSm1SS3ptVDNvbjJHTTZ4SV9tUU9XSHRyd1U1ZFZVcjVoYUZnVzVidl9VY0RzUUdsRkdLMWR6b3ZwZ29RMGFWanpmUWlkRko2Ull3eEQyVWVUNjNFV0tuSm9QMDgxV3Y4OS1B?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T10:34:43+00:00", "published_display": "13 Jul 2026 10:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Analyst Ratings, Stock Forecast and Price Target", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T03:09:35+00:00", "published_display": "13 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPclRZS1B6QzF6SndzNnIyOFZaekRzX2g0Qk93bUpfUXhIRm1XYXJkODgzaDhVRmk4UThQUE5lM2YzZUxOZXZ6SWVBWENSQlNWNFB6cWNod0QzVndVcHRVdXRQb3pEMVp2X3hmS1NfZnRhd2lHYldobXY3dnIwRzVYNkswdFNIVGRRQ1V4eTIwVWJCU1lYekgzVFh6NUktVWhlYV9DZWpqb1c2WF83SFozYTBNRVEyMlJpYkxkMTI0amd0SkxYZWc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-12T18:37:26+00:00", "published_display": "12 Jul 2026 18:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQVUZmcEVWci0wNm50LS1sR1d0UGZXaHJQbW5BLVhoOGs2cHNJMGNmb0NaWlA5MTMzaXU3OFR5VmJOTWk0MlFHNXI3NkVjNjlUNnc5ekcwSDZlWU8wWHNzVlppUzlPNlNtSGp0WjBZQjNGT2VxemNRVXVvbzR2N196aXZWRVBTbzhORTUydjdDb1BtU0tqZ2RjQWY3Mk5QN1gtcWZLbTFzbWs3NEdxSG1QamF0N3R1TVZiNGhhSm1oNlhPUWQyYkhXWnNVRE0?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T09:32:31+00:00", "published_display": "11 Jul 2026 09:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOWUtPeXFhVmNlMG9yczZQSmloREtPelJ1dUk5X25RN2xjWTh0eW9yNW1nVmRTV0dFSWh4akl3X0gyaDZwaXJQbUZ1bkZRanIxUzdqbnNpWHV1ckhVNzBfako4QVRta0tGdXdBc0s4TjdQQk54enVNd2xvTjNMem4tN0l5R2VFdTVrNkdsM2VFbHpKVXl6cktRNHg3WTBKenpWbmZFa0NuU3pYNUNqbU1KWUVKUWF4TUp1dllpOF8xeHpIOXVCNnc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-10T18:02:26+00:00", "published_display": "10 Jul 2026 18:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen highlights its science-driven pipeline as investors weigh long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUDBmSW42T3VmdXM5ekRNRDVaYmlyVEI4NDFENGpkUGlMU2VINE1PMEl2NWU1bUU5UDJJblUyS0tXUk5BNmRnanZ5ZjhSWFgwNThzQmtiRjVkUnlJV3MtVWVSb2xWaHVsdzh2dEh1WjBzeFY2elRqYjhFYzJKdnZWWVRRejMxY3Y1WnItOHA0YTNJWTRMbUxwdGQ4N192RW1oMXp1Q2NlYWx0TGtHS2k3bHh5OFBUeWV2N25pVmZnSGI0LVdwc2hMUmJ1SWQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-07T11:26:47+00:00", "published_display": "07 Jul 2026 11:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQTG9jeEVHV1R0YzRUd2ZMakFrdFgyNW1oY3ZhRXFlT3ZKLWZUZlhaOHdsdld5ZWxmR1k1M0E5V0pBNGN2RjctZXhRZHFfNmpNdjBmQXpuc2Y5N3hPNUY2M3NRdjV3cGZLT19MLWI3c1VDaFRoTk1rRGlNM2JkYzZsdlkxSkVlUG9nb2FlaXhoR3lqc09fV1RN?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaWJ3VU81UWdRY1V5UnE3c0F5Y0Z6aGE1aGViUjJZZ2syRjZ0TEJnNENkRERheWxHUGJHeEt2U3VQRHloZmN6SjR1OHpsZnhOLWpOWXVja0xQSmszWHY4Wm1YbUVEcXg2NEExcGRXQnF0Q2pWWXVtc1pzQVFYWUU2UGtCNENKLVlsbzBRMjBtSy1NNFdFQ1RRNWh0ZGZwNTlkTGZhN2k4cFhrZw?oc=5", "source_name": "StockStory", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen or Biogen: Which Biotech Stock Appears Better Poised?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxON1BCVkVBZzJtX2tLMjg3OTJiV1NlYnYxcHd6ZjdMRmRoaEpnV2tEYkdPOUFKQmc3ZDQ0WWlQXy1fTXYtd1NhQm9sZDdGajBYMVNsQ250TkhjNU1lUGNDSnpldUZseWpFb3pHT1NodEd6T2xIRmFVSU1jU0hNemZCaVNfTWlwYnp6UnVhM1FQcDBOMG81dXdJZHpSbw?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOeGV4VzN2aDFGX1MxcDROeHdGRDlvaUZQbi1sUnNQc2RUYWhUcXduY0FCUzcxaDBfSzJFeElMNjZjdm95RUF1U3Jqel9RRGQtV2JnNmF2T29NZlkwVkxlLVRKV0E4XzVxS1FLWVMtOHdsdDlqT01vcGxlQjBmcUR3RWgyQXlFZlZQWkV2bXpoSWpmTmFscHlFRzRuMA?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Stock After Horizon Deal And Strong Multi\u2011Year Gains Is Price Still Reasonable", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQUEk5QTkyT0x2SHp2RFl3SlVLWXR4Zm52N090UmJyLVp5Z0VYdFlEeERFV1phOE1FS1ViYWdrNkh5VmNLbXJtWFp4b1FBUVF1MHdSN21zYXFOWWdVSjJLanlWVTUxbkQyTGhGYV9tVHJqVGgwOVZKWmFHYmJjeXZIN0xXVVZZVlA4MFMwZUZfU29tdXUybnJWeUFkMU1DQ1pocXBUVHhweUpoRjg3ZjkyaldnWGw1Z1U?oc=5", "source_name": "TradingView", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPOHZoUHZHV2tSUk1FamJ2dlpGRHhwRF9wUlU5cVIyYVQyTFJuSjlfOXpJUkEzbVI4aWRPd3hVTXZkX2xvaVNzNVR4bDdVakhGdmNoWE9PUi01NVdGZnhnbUVfd1lMYl80N3B2UUtRSDQ2aWJfN0F2VTJySHB4Q253WXNLam10UEJnU1E3bndnY3plRnlRTm5wdEFqeUdnZw?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen finance and R&D chiefs will speak in a public webcast May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNSWxzODIxSk5CNEwxUWJLU0JZb3ZhOWhWcVFSZHZqOFVTcDVZc29zeVBFdU9QRWcycTRvSXVHa1ZHT2ZENUU0MkdnS2JhOEpMaGFYb2ZPVG9HVGo3aERJTkNnT01jWnhaWGpCRlNuWVo5cDNyVnozVHFqUnpmWVMtQ3pMUGhYSENWaGhFRzI2Q2dXTHJvTHBsQVBpaDRXMHdtYWR0dUFPSmF3TFkydGlVVGZqd1E3dw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNnk5T1gtWUJjNV9oRlJrTS1YQ09Gb2tRVDdyellvTGp1TFdRelI0a25ha0VXOW5IZnJDRkFlVzRQYm51Tm5LZ1ZkUGN3QU9xMUdVX1VoclkyalFNbktmOG5PdDBENzB6QXlIWVFzVFU5R01DYXRKQjZqWmZTMFY3U0swYmZrNVdQUVE1OWltMWJFZl91LWhLT2ZXOHNLaXh0SkcxeGpBdFVDQmVaYmZXRWhlWWdFOVVnVncwTGNHUVVhQ0ZuOVd5YzZGTWI3OUNlbVhmYWIyeXR0bW1wUGQtQjN1dGdCTm1EdzRBck1NSUZ6RUQzNTRhNGhBUQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen CEO Teases 2026 As \u2018Springboard Year\u2019 After 14 Blockbusters And 18 Record Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQcUhyZXo1WVlWVDFnVjdiSlFLMFM4LVBENVRORV82TnlNQXQxd1ZJMEh1VmdzSGVlYXo3Tm0xOERxYnRVTUowUm5Db181d3lha0F6LU96UGtUZ0dYdnZYeGtncGtFejZzcktuMlRjVVdSR1FfR2swb3huNmYxeEFiTUFKSVRRTHVaMDRBZEFBcEN1S1p5NzVneGhsUXphTFZwVkdoa3R1MGZnTFA1YkE3M0NveTFpeHRLRDlpX2tJT2JaQS1RS01MOHdGd2tZZHFqZm1SejgzT0dPR2M4?oc=5", "source_name": "Stocktwits", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq falls 1.5% amid heavy rotation out of tech stocks; Amgen boosts Dow", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPdHJkeV9sUHZlOWNBbFZHMVNCS0g4S2Vsc3VIMVhmSVNXQklSTWw3Q2ZBVHZMelh1MktteDZibXJZeVhEMk9JM29JZGxCRG5fel9wendVLTdFT2dVYWgwS1BlY2xyNHUwRk5NbDVEOUlpa1A5RjIxWldrUC0tQnVGbGR1U2hNYkgweDZYUzYzSnF3VTU5OVJvYjlKbmZKZ3diUFNtbFl6MTdMb3pPaDVJd1F6VTBLQ0NDWl9WcWpOOE1SdkRYMHR5VnEtcTYtUk0?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOUzdHeGdUbzBLOVBRRDVBWFY0VGdaZlpIRGxjQ012VFhxVjU4ZXAyZm5mVGZQZnE0cWhNaHFWVE55TW5xeEEtZDRsNm55MkRkeDJyWVdINS1haDNQS3JPYlNTZG8tbVdSX25walRqWTNKTXMwTmFvTUpqeGZBazRYT18zZWFRSXhMSUFCbjZKNTA2bDR0ZVVTVUZRUFpqaDZoWWhDekdKb29wdjZnLU12ZmNGbXRxWkhQYS13YXZ3QzFRVGVnOENReFVjM0l2NWM1WTBFcHpUdDJyZVNpYWV0aDBPRkExdw?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Ignore The Insider Selling In Amgen", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPU0NJb09EU2V4d1JQenJwUnh6Zk5DcWZ1NlFDWUtmdWFFOU5yVkFkTVNqTERGQ2w2YURnYVIxOEg0NS1Vc0VUUjUta240U1hCd21ObUZHcncxMlp0WU96ODRZeHp5dC1ha0FFQmxuRVUtTU9oRlJZZ1A5dUk2dmMxMnJ1dmhELXZaWmZjaTFSTVFudk8wNkNXT3NFT05JM3VwRk9WOEVtQjJPNW9tZlVCNnpYNHNmYXc0R1o40gHAAUFVX3lxTE94N1N6QVR3cy13LVRaVHQ5SjZQQWZSMy1VNF85djNLbHZrTEo4MnZmOHNwOGRCQ1JHWE9POFdQMmduRlJ6ZEFkTW83bThUZk85Qnc2SlVKcVJEYUd3aV9SSmYwNVR1enhuN0JMaWFKaThBZFRCRlJieXR0MkdlT3NReS11UU1CUTZFWXFtU2x3VllKZ0VhR0xEc0toSjhYbS1aT1ZFTkM4Q3RHal95alljc3NabTRMTzhmbW5ZdlF6LQ?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5", "source_name": "The American Journal of Managed Care\u00ae (AJMC\u00ae)", "published_at": "2025-10-06T07:00:00+00:00", "published_display": "06 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 108, "total_relevant": 51, "sentiment_summary": {"positive": 19, "negative": 5, "neutral": 27, "score": 55, "total": 51, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 16.85, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 7.5, "count": 13}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 363.39, "latest_week": "2026-07-10", "one_week_move": -2.9, "four_week_move": 2.3, "twelve_week_move": 3.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.166612, "market_dynamics_buy_signal": false, "relative_strength": -4.101484, "fair_value_gap": 24.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 56.8189, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.9% over one week, +2.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 10}, {"label": "Market source", "count": 8}, {"label": "Ad Hoc News", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "24/7 Wall St.", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "GuruFocus", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 51}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 13}, {"label": "Regulatory and legal", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "51", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-2.9% over one week, +2.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 81/100"}], "updated_at": "2026-07-16T21:40:59.331404+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}